For MSH4, methylation odds significantly increased with late tumor stage [OR: 6.82, 95% CI 2.42–21.1, p < 0.001] and muscle-invasive disease [OR: 7.25, 95% CI 2.43–25.0, p < 0.001] (Fig. 3d). The gene discussed is MSH4; the disease is neoplasm.